Natural Product Inhibitors of Topoisomerases: Review and Docking Study
- PMID: 28079013
- DOI: 10.2174/1389203718666170111114442
Natural Product Inhibitors of Topoisomerases: Review and Docking Study
Abstract
Since ancient times, natural products have been used in treating various diseases effectively and safely. Nowadays, these natural compounds are submitted to sophisticated methodologies from isolation, computing, analytical, and even serving as pharmacophore suggestions for synthesis. The substances extracted from marine species, plants, and microorganisms present activities beneficial to our health, including protection against malignant tumors. The topoisomerase enzymes play an important role in DNA metabolism, and searching for enzyme inhibitors is an important target in the search for new anticancer drugs. This review discusses this problem, reporting research involving alkaloids, terpenes, flavonoids, xanthones, coumarins, acetogenins, and in addition, includes a docking study with our Brazilian diterpenes to topoisomerases I and II. The better compound, the trachylobane 1, forms one hydrogen bond when submitted to docking with Topo I (with the ASP533 residue) and two with residues in Topo II (THR213 and TYR188). The difference observed in the energy of formation can be attributed to hydrogen-bond interactions. The difference observed in the energy of formation can be attributed to hydrogen-bond interactions.
Keywords: Alkaloids; cancer; docking; flavonoids; terpenes; topoisomerases.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.
Similar articles
-
Natural Products as Anti-Cancerous Therapeutic Molecules Targeted towards Topoisomerases.Curr Protein Pept Sci. 2020;21(11):1103-1142. doi: 10.2174/1389203721666200918152511. Curr Protein Pept Sci. 2020. PMID: 32951576 Review.
-
DNA topoisomerase-directed anticancerous alkaloids: ADMET-based screening, molecular docking, and dynamics simulation.Biotechnol Appl Biochem. 2016 Jan-Feb;63(1):125-37. doi: 10.1002/bab.1346. Epub 2015 Apr 10. Biotechnol Appl Biochem. 2016. PMID: 25594242
-
Flavonoids and their derivatives as DNA topoisomerase inhibitors with anti-cancer activity in various cell models: Exploring a novel mode of action.Pharmacol Res. 2024 Nov;209:107457. doi: 10.1016/j.phrs.2024.107457. Epub 2024 Oct 9. Pharmacol Res. 2024. PMID: 39389401 Review.
-
Discovery and Development of Topoisomerase Inhibitors as Anticancer Agents.Mini Rev Med Chem. 2016;16(15):1219-1229. doi: 10.2174/1389557516666160822110819. Mini Rev Med Chem. 2016. PMID: 27549098 Review.
-
DNA topoisomerases as molecular targets for anticancer drugs.J Enzyme Inhib Med Chem. 2020 Dec;35(1):1781-1799. doi: 10.1080/14756366.2020.1821676. J Enzyme Inhib Med Chem. 2020. PMID: 32975138 Free PMC article. Review.
Cited by
-
Ginsenoside Rg3-loaded, reactive oxygen species-responsive polymeric nanoparticles for alleviating myocardial ischemia-reperfusion injury.J Control Release. 2020 Jan 10;317:259-272. doi: 10.1016/j.jconrel.2019.11.032. Epub 2019 Nov 26. J Control Release. 2020. PMID: 31783047 Free PMC article.
-
Novel drug isolated from mistletoe (1E,4E)-1,7-bis(4-hydroxyphenyl)hepta-1,4-dien-3-one for potential treatment of various cancers: synthesis, pharmacokinetics and pharmacodynamics.RSC Adv. 2020 Jul 24;10(46):27794-27804. doi: 10.1039/d0ra03674a. eCollection 2020 Jul 21. RSC Adv. 2020. PMID: 35516963 Free PMC article.
-
Combination of bioaffinity ultrafiltration-UFLC-ESI-Q/TOF-MS/MS, in silico docking and multiple complex networks to explore antitumor mechanism of topoisomerase I inhibitors from Artemisiae Scopariae Herba.BMC Complement Med Ther. 2023 Sep 12;23(1):317. doi: 10.1186/s12906-023-04146-x. BMC Complement Med Ther. 2023. PMID: 37700261 Free PMC article.
-
Flavonoids as Putative Epi-Modulators: Insight into Their Binding Mode with BRD4 Bromodomains Using Molecular Docking and Dynamics.Biomolecules. 2018 Jul 23;8(3):61. doi: 10.3390/biom8030061. Biomolecules. 2018. PMID: 30041464 Free PMC article.
-
Discovery of novel natural products as dual MNK/PIM inhibitors for acute myeloid leukemia treatment: Pharmacophore modeling, molecular docking, and molecular dynamics studies.Front Chem. 2022 Jul 22;10:975191. doi: 10.3389/fchem.2022.975191. eCollection 2022. Front Chem. 2022. PMID: 35936081 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources